A Novel Method for Ex Vivo Stimulation of Mesenchymal Stem Cells via Invariant Natural Killer T Cell Activation with α-Galactosylceramide.

被引：0
|
作者：
Ishii, R. [1 ]
Kawaguchi, E. [1 ]
Yamakawa, T. [1 ]
Ishigooka, H. [1 ]
Ikeda, T. [1 ]
Ishiyama, R. [1 ]
Saiga, K. [1 ]
Takagi, T. [1 ]
Ishii, Y. [2 ]
Tanabe, K. [1 ]
机构：
[1] Tokyo Womens Med Univ, Tokyo, Japan
[2] Juntendo Univ, Grad Sch Med, Dept Immunol Diag, Tokyo, Japan
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C61
引用
收藏
页码：898 / 899
页数：2
相关论文
共 50 条
  • [1] In-vivo stimulation of macaque natural killer T cells with -galactosylceramide
    Fernandez, C. S.
    Jegaskanda, S.
    Godfrey, D. I.
    Kent, S. J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 173 (03): : 480 - 492
  • [2] Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide
    Hogan, Andrew E.
    O'Reilly, Vincent
    Dunne, Margaret R.
    Dere, Ravindra T.
    Zeng, Shijuan G.
    O'Brien, Cashel
    Amu, Sylvie
    Fallon, Padraic G.
    Exley, Mark A.
    O'Farrelly, Cliona
    Zhu, Xiangming
    Doherty, Derek G.
    CLINICAL IMMUNOLOGY, 2011, 140 (02) : 196 - 207
  • [3] The Roles of 3′ and 4′ Hydroxy Groups in α-Galactosylceramide Stimulation of Invariant Natural Killer T Cells
    Xia, Chengfeng
    Zhang, Wenpeng
    Zhang, Yalong
    Chen, Wenlan
    Nadas, Janos
    Severin, Ryan
    Woodward, Robert
    Wang, Bin
    Wang, Xin
    Kronenberg, Mitchell
    Wang, Peng G.
    CHEMMEDCHEM, 2009, 4 (11) : 1810 - 1815
  • [4] Ex vivo purification and characterization of human invariant natural killer T cells
    Sharma, Ashish Arunkumar
    Chew, Leon
    Ladd, Mihoko
    Jen, Roger
    Lavoie, Pascal M.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2011, 373 (1-2) : 1 - 7
  • [5] Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice
    Homma, Tsuneaki
    Kinugawa, Shintaro
    Takahashi, Masashige
    Sobirin, Mochamad Ali
    Saito, Akimichi
    Fukushima, Arata
    Suga, Tadashi
    Takada, Shingo
    Kadoguchi, Tomoyasu
    Masaki, Yoshihiro
    Furihata, Takaaki
    Taniguchi, Masaru
    Nakayama, Toshinori
    Ishimori, Naoki
    Iwabuchi, Kazuya
    Tsutsui, Hiroyuki
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2013, 62 : 179 - 188
  • [6] Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination Postinfluenza
    Barthelemy, Adeline
    Ivanov, Stoyan
    Hassane, Maya
    Fontaine, Josette
    Heurtault, Beatrice
    Frisch, Benoit
    Faveeuw, Christelle
    Paget, Christophe
    Trottein, Francois
    MBIO, 2016, 7 (06):
  • [7] In vivo activation of invariant Vα14 natural killer T cells by α-galactosylceramide sequentially induces Fas-dependent and -independent cytotoxicity
    Lisbonne, M
    Hachem, P
    Tonanny, MB
    Fourneau, JM
    Sidobre, S
    Kronenberg, M
    Van Endert, P
    Dy, M
    Schneider, E
    Leite-De-Moraes, MC
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (05) : 1381 - 1388
  • [8] Activation of natural killer T cells with α-galactosylceramide accelerates atherosclerosis in mice
    Nakai, Y
    Iwabuchi, K
    Mishima, T
    Ishimori, N
    Watano, K
    Onoe, K
    Van Kaer, L
    Kitabatake, A
    CIRCULATION, 2003, 108 (17) : 163 - 163
  • [9] Reciprocal Interactions Between Human Mesenchymal Stem Cells and γδ T Cells Or Invariant Natural Killer T Cells
    Prigione, Ignazia
    Benvenuto, Federica
    Bocca, Paola
    Battistini, Luca
    Uccelli, Antonio
    Pistoia, Vito
    STEM CELLS, 2009, 27 (03) : 693 - 702
  • [10] Effects of cyclosporin a on the activation of natural killer T cells induced by α-galactosylceramide
    Kajiwara, Takashi
    Tomita, Yukihiro
    Okano, Shinji
    Iwai, Toshiro
    Yasunami, Youichi
    Yoshikai, Yasunobu
    Nomoto, Kikuo
    Yasui, Hisataka
    Tominaga, Ryuji
    TRANSPLANTATION, 2007, 83 (02) : 184 - 192
12345